Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.70 |
| ▸ | LTA4H | P09960 | 2/20 | 0.58 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | ACP3 | P15309 | 1/20 | 0.42 |
| ▸ | BACE1 | P56817 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Anisole SCHEMBL28841355 | 1.00 | CA4 (0.70) | CA4LTA4HCES2CES1CA1 | |
| Anisole SCHEMBL15125 | 1.00 | CA4 (0.70) | CA4LTA4HCES2CES1CA1 | |
| Anisole SCHEMBL10582653 | 0.98 | CA4 (0.67) | CA4LTA4HCES2CES1CA1 | |
| Anisole SCHEMBL9825115 | 0.98 | CA4 (0.67) | CA4LTA4HCES2CES1CA1 | |
| 1,4-Dimethoxybenzene SCHEMBL28441075 | 0.87 | CA1 (0.65) | CA4CES2CES1CA1CA2 | |
| 1,4-Dimethoxybenzene SCHEMBL9648022 | 0.87 | CA1 (0.65) | CA4CES2CES1CA1CA2 | |
| Anisole SCHEMBL6154353 | 0.85 | CA4 (0.70) | CA4LTA4HCES2CES1CA1 | |
| Anisole SCHEMBL8472521 | 0.84 | CA4 (1.00) | CA4LTA4HCES2CES1CA1 | |
| Anisole SCHEMBL30601749 | 0.84 | — | — | |
| Anisole SCHEMBL28813915 | 0.84 | CA4 (1.00) | CA4LTA4HCES2CES1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504819-A | Method for selectively catalyzing isocyanate hydroboration by organic aluminum compound and application | 北京理工大学 | 2025-02-25 | — | — | CN | claimed |
| CN-118791720-A | Method for preparing polyester by catalyzing ring-opening polymerization of cyclic monomer based on sodium salt catalyst of urea-amino acid | 南京工业大学 | 2024-10-18 | — | — | CN | claimed |
| CN-118598875-A | Pyrimidine diketone amide compound and preparation method and application thereof | 广州医科大学 | 2024-09-06 | — | — | CN | claimed |
| CN-117625031-B | Preparation method of wear-resistant corrosion-resistant polyurethane self-leveling floor coating | 山东默特尔工程科技有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-117625031-A | Preparation method of wear-resistant corrosion-resistant polyurethane self-leveling floor coating | 山东默特尔工程科技有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-114195671-B | Asymmetric malonyl aniline compound and synthesis method thereof | 河南师范大学 | 2023-09-22 | — | — | CN | claimed |
| CN-106892893-B | Method for preparing lactide from lactic acid oligomer | 中国科学院长春应用化学研究所 | 2020-09-25 | — | — | CN | claimed |
| CN-119504819-A | Method for selectively catalyzing isocyanate hydroboration by organic aluminum compound and application | 北京理工大学 | 2025-02-25 | — | — | CN | disclosed |
| CN-119019387-A | 3-Substituted-1-H-indole pyrazole derivative compound, and preparation method and application thereof | 贵州大学 | 2024-11-26 | — | — | CN | disclosed |
| CN-118852224-A | Beta-ketoamine non-noble metal complex and preparation method and application thereof | 北京理工大学 | 2024-10-29 | — | — | CN | disclosed |
| CN-118791720-A | Method for preparing polyester by catalyzing ring-opening polymerization of cyclic monomer based on sodium salt catalyst of urea-amino acid | 南京工业大学 | 2024-10-18 | — | — | CN | disclosed |
| CN-118598875-A | Pyrimidine diketone amide compound and preparation method and application thereof | 广州医科大学 | 2024-09-06 | — | — | CN | disclosed |
| CN-118125852-B | Reinforced preform carbon-carbon composite material and preparation method thereof | 杭州幄肯新材料科技有限公司 | 2024-07-16 | — | — | CN | disclosed |
| EP-1372632-A1 | PROLIFERATIVE ACTIVATOR RECEPTOR (PPAR) COMPOUNDS | Pfizer Products Inc. (US) | 2004-01-02 | — | — | EP | disclosed |
| EP-1360172-A1 | PPAR AGONISTS | Pfizer Products Inc. (US) | 2003-11-12 | — | — | EP | disclosed |
| US-20020169192-A1 | PPAR compounds | HAYWARD CHERYL M (US) | 2002-11-14 | — | — | US | disclosed |
| US-20020165282-A1 | Peroxisome proliferator activator receptor (PPAR) agonists; atherosclerosis and cardiovascular disorders; for example, 3-(4-(2-(3-(2,4-dimethoxy-phenyl)-1-heptyl-ureido)-ethyl)-phenyl)-2-ethoxy -propionic acid | HAYWARD CHERYL M (US) | 2002-11-07 | — | — | US | disclosed |
| WO-2002064549-A1 | PPAR AGONISTS | PFIZER PRODUCTS INC. (US) | 2002-08-22 | — | — | WO | disclosed |
| WO-2002064130-A1 | PROLIFERATIVE ACTIVATOR RECEPTOR (PPAR) COMPOUNDS | PFIZER PRODUCTS INC. (US) | 2002-08-22 | — | — | WO | disclosed |
| CN-1177343-A | Cell adhesion inhibitors | BIOGEN INC (US) | 1998-03-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020165282-A1 | Peroxisome proliferator activator receptor (PPAR) agonists; atherosclerosis and cardiovascular disorders; for example, 3-(4-(2-(3-(2,4-dimethoxy-phenyl)-1-heptyl-ureido)-ethyl)-phenyl)-2-ethoxy -propionic acid | PPARA, PPARG, PPARD | CA4 4861/4885LTA4H 1224/4885CES2 2133/4885 |
| US-20020169192-A1 | PPAR compounds | PPARA, PPARG, PPARD | CA4 4849/4885LTA4H 848/4885CES2 1525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.